Cantor Fitzgerald maintains Varonis Systems at Overweight, lowers price target to $49.75 from $55

Cantor Fitzgerald kept its Overweight rating on Varonis Systems but reduced its price target to $49.75 from $55, a 9.5% cut. This implies a 1.6% upside from the Nov 3 close of $48.96. Recent analyst targets for the company range from $49.75 to $50.

Original reporting
Published Nov 4, 2026, 11:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cantor Fitzgerald maintains Varonis Systems at Overweight, lowers price target to $49.75 from $55 — source image
Decision brief

The 30-second read

Low
01

Why it matters

The downgrade may lead to short-term price weakness but does not indicate a fundamental shift.

02

Market read

A modest analyst target cut with limited trading relevance; likely only affects short-term sentiment.

03

What to watch

Potential upcoming product launches or contract wins not covered in the brief could offset the target reduction.

Relevance 4/10Novelty 2/10Timing: same-day after market

Background

Cantor Fitzgerald's research note adjusts its outlook for Varonis Systems, reflecting a revised valuation.

Market effects

Minimal impact on the broader cybersecurity sector; analysts may reassess peers.

Limited to U.S. markets where Varonis trades.

Low; the change does not affect global market dynamics.

Counterpoint

Some investors may view the target cut as an overreaction and see buying opportunity.

Key entities

  • Cantor Fitzgerald

    Equity research provider issuing the target cut.

  • Varonis Systems

    Cybersecurity data management firm listed on NASDAQ.

Related articles

$VRNSMed

Varonis Systems (NASDAQ:VRNS) beats Q3 2026 sales expectations

Varonis Systems (VRNS) reported Q3 2026 revenue of $189.5M, up 17.3% YoY and 1.5% above estimates. Adjusted EPS of $0.09 beat consensus by $0.06. Operating margin declined to -25.2%, while free cash flow margin improved to 13.6%. Billings grew 7.1% YoY to $192.9M. Analysts expect 17.7% revenue growth over the next 12 months.